ERIS

Eris Lifesciences Share PriceEris Lifesciences

₹568.4
0.45 (0.08%)
As on 23 March, 2023 | 08:06 BSE: 540596 NSE: ERIS

Eris Lifesciences Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Eris Lifesciences

Start SIP

Eris Lifesciences Share Price

  • Over 1 Month -9.27%
  • Over 3 Month -13.78%
  • Over 6 Month -18.66%
  • Over 1 Year -20.21%

Eris Lifesciences Key Statistics

P/E Ratio 19.5
PEG Ratio 37.6
Market Cap Cr 7,730
Price to Book Ratio 4.1
EPS 30.8
Dividend 1.3
Relative Strength Index 23.56
Money Flow Index
MACD Signal -11.82
Average True Range 17.21

Eris Lifesciences Investment Rating

  • Master Rating:
  • Eris Lifesciences has an operating revenue of Rs. 1,588.30 Cr. on a trailing 12-month basis. An annual revenue growth of 12% is good, Pre-tax margin of 33% is great, ROE of 21% is exceptional. The company has a reasonable debt to equity of 2%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 65 which is a FAIR score but needs to improve its earnings, a RS Rating of 30 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 153 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Eris Lifesciences Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 327350322277
Operating Expenses Qtr Cr 206214203181
Operating Profit Qtr Cr 126141126102
Depreciation Qtr Cr 16161515
Interest Qtr Cr 3771
Tax Qtr Cr 119128
Net Profit Qtr Cr 991159687

Eris Lifesciences Technicals

EMA & SMA

Current Price
₹568.4
0.45 (0.08%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • 602.76
  • 50 Day
  • 623.64
  • 100 Day
  • 642.93
  • 200 Day
  • 661.7
  • 20 Day
  • 611.1
  • 50 Day
  • 625.51
  • 100 Day
  • 650.49
  • 200 Day
  • 667.81

Eris Lifesciences Resistance and Support

PIVOT
₹569.99
Resistance
First Resistance 574.67
Second Resistance 581.39
Third Resistance 586.07
RSI 23.56
MACD Single Line -11.82
MACD -17.22
Support
First Resistance 563.27
Second Resistance 558.59
Third Resistance 551.87

Eris Lifesciences Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 61,333 4,641,068 75.67
Week 562,969 43,010,862 76.4
1 Month 150,642 11,254,467 74.71
6 Month 80,162 5,550,417 69.24

Eris Lifesciences Result Highlights

Eris Lifesciences Synopsis

NSE-Medical-Biomed/Biotech

Eris Lifesciences is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1215.73 Cr. and Equity Capital is Rs. 13.59 Cr. for the Year ended 31/03/2022. Eris Lifesciences Ltd. is a Public Limited Listed company incorporated on 25/01/2007 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24232GJ2007PLC049867 and registration number is 049867.
Market Cap 7,730
Sales 1,298
Shares in Float 6.39
No of funds 115
Yield 1.29
Book Value 4.03
U/D Vol ratio 0.3
LTDebt / Equity
Alpha -0.08
Beta 0.33

Eris Lifesciences

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 52.7%52.29%52.3%
Mutual Funds 9.64%10.38%10.36%
Foreign Portfolio Investors 15.5%15.39%15.35%
Financial Institutions/ Banks
Individual Investors 21.45%21.26%21.34%
Others 0.71%0.68%0.65%

Eris Lifesciences Management

Name Designation
Mr. Amit Bakshi Chairperson & Managing Director
Mr. Krishnakumar Vaidyanathan COO & Executive Director
Mr. Inderjeet Singh Negi Executive Director
Mr. Kaushal Shah Executive Director
Mr. Rajeev Dalal Independent Director
Mr. Vasudevan Sujesh Independent Director
Ms. Kalpana Unadkat Independent Director
Mr. Prashant Gupta Independent Director

Eris Lifesciences Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Eris Lifesciences MF Shareholding

Name Amount(cr)
Kotak Emerging Equity Scheme Growth 23963
UTI Flexi Cap Fund Regular Plan Growth 23945
Franklin India Smaller Companies Fund Growth 7309
HSBC Midcap Fund Growth 7089
Aditya Birla Sun Life Equity Hybrid '95 Fund Growth 7046

Eris Lifesciences FAQs

What is Share Price of Eris Lifesciences ?

Eris Lifesciences share price is ₹568 As on 23 March, 2023 | 07:52

What is the Market Cap of Eris Lifesciences ?

The Market Cap of Eris Lifesciences is ₹7729.8 Cr As on 23 March, 2023 | 07:52

What is the P/E ratio of Eris Lifesciences ?

The P/E ratio of Eris Lifesciences is 19.5 As on 23 March, 2023 | 07:52

What is the PB ratio of Eris Lifesciences ?

The PB ratio of Eris Lifesciences is 4.1 As on 23 March, 2023 | 07:52

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number